In CommitteeFiled Jun 4, 2026
Sponsor: Rep. Wasserman Schultz, Debbie [D-FL-25] (D)
Latest Action
Referred to the House Committee on Energy and Commerce.
Jun 4, 2026
Summary
The bill orders the National Institutes of Health to increase basic, translational, and clinical research on polycystic kidney disease (PKD) and to work with partners across government, academia, and industry. It also requires a working group to develop a comprehensive PKD research roadmap and report its findings to Congress within two years. The goal is to accelerate treatments for the roughly 500,000 Americans affected by this costly, life‑threatening disease.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 9169 changes status, plus AI-powered summaries and stage predictions.
Sign up free